Data for: Antidepressants and suicidality: A re-analysis of the re-analysis.

Data on number of suicide and suicide attempts from the Integrated Safety Summaries included in the New Drug Approval registration packets for 14 antidepressants approved between 1991 and 2013 as reported by Khan A, Fahl Mar K, Gokul S, Brown WA. Decreased suicide rates in recent antidepressant clinical trials. Psychopharmacology (Berl). 2018;235(5):1455–62. and Hengartner MP, Plöderl M. Newer-Generation Antidepressants and Suicide Risk in Randomized Controlled Trials: A Re-Analysis of the FDA Database. Psychother Psychosom [Internet]. 2019;1–2. Available from: https://www.karger.com/Article/FullText/501215本数据集涵盖1991年至2013年间获批的14种抗抑郁药的新药注册申报资料所附综合安全摘要中记录的自杀及自杀未遂例数，相关数据引自以下两篇学术文献： 1. Khan A, Fahl Mar K, Gokul S, Brown WA. 近期抗抑郁药临床试验中的自杀率下降[J]. 精神药理学（柏林）, 2018, 235(5):1455–1462. 2. Hengartner MP, Plöderl M. 新一代抗抑郁药与随机对照试验（Randomized Controlled Trials）中的自杀风险：美国食品药品监督管理局（Food and Drug Administration, FDA）数据库的再分析[J]. 心理治疗与心身医学, 2019;1–2. [在线资源]. 可从以下网址获取：https://www.karger.com/Article/FullText/501215